跳至主要内容
临床试验/EUCTR2008-004723-37-ES
EUCTR2008-004723-37-ES进行中(未招募)不适用

Eficacia y tolerancia de la aplicación tópica de hidróxido potásico (10% y 15%) en el tratamiento del molusco contagioso

IDIAP JORDI GOL I GURINA0 个研究点开始时间: 2009年4月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Pacientes diagnosticados de molusco contagioso.
  • Edad entre 2 y 6 años
  • Firma del consentimiento informado.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pacientes con inmunodepresión
  • Paciente tratado tópicamente durante el último mes
  • Lesiones en cara, cuello y/o zonas genitales
  • Pacientes presuntamente no cumplidor.

研究者

发起方
IDIAP JORDI GOL I GURINA

相似试验

进行中(未招募)
1 期
Study to evaluate efficacy and safety of topical administration of timolol maleate 0.5% solution in the treatment of Child Proliferative Hemangioma Early Stage SurfaceChildren Superficial Hemangioma
EUCTR2013-005199-17-ESInstitut de Recerca HSCSP70
招募中
3 期
The efficacy of topical Hydroquinon with and without using Erbium YAG LASER in treatment of melasmaMelasma.L81.1Chloasma
IRCT20181201041812N1Tehran University of Medical Sciences27
已完成
不适用
The effect of topical application of human milk on umbilical cordumbilical cord care.Condition originating in the perinatal period, unspecified
IRCT201102145830N1Islamic Azad University, Sari Branch150
已完成
3 期
To study the effect of combination of Nadifloxacin 1% + Adapalene 0.1% gel on acne
CTRI/2013/05/003616Wockhardt Limited100
进行中(未招募)
不适用
Efficacy and local tolerability of topically applied heparin (Heparin2,400 IU/ml Cutaneous Spray) on the suitability of newlyconstructed primary arteriovenous Fistulas in haemodialysedpatientsThis placebo-controlled, randomized and double-blinded pilot study aims to confirm the previousstudy performed by Stuard et al. (2010) by proving clinically efficacy and local tolerability of topicallyapplied heparin (Heparin 2,400 IU /ml Cutaneous Spray) in comparison to placebo on suitability ofnewly constructed primary arteriovenous fistulas in haemodialysed patients AVF at 7 weeks (±1week) after first study drug administration.
EUCTR2011-000455-16-ATCYATHUS EXQUIRERE PharmaforschungsGmbH56